authors
- Hijazi, Ziad
- Hohnloser, Stefan H
- Oldgren, Jonas
- Andersson, Ulrika
- Connolly, Stuart J
- Eikelboom, John
- Ezekowitz, Michael D
- Reilly, Paul A
- Siegbahn, Agneta
- Yusuf, Salim
- Wallentin, Lars
Response to Letter Regarding Article, “Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis”
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 25, 2014
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Atrial Fibrillation (MeSH)
- Benzimidazoles (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Female (MeSH)
- Humans (MeSH)
- Kidney (MeSH)
- Male (MeSH)
- Warfarin (MeSH)
- beta-Alanine (MeSH)
published in
- Circulation Journal